nodes	percent_of_prediction	percent_of_DWPC	metapath
Olanzapine—FMO3—Tamoxifen—pancreatic cancer	0.256	0.375	CbGbCtD
Olanzapine—ORM1—Erlotinib—pancreatic cancer	0.0647	0.0949	CbGbCtD
Olanzapine—ALB—Erlotinib—pancreatic cancer	0.0272	0.0399	CbGbCtD
Olanzapine—ALB—Irinotecan—pancreatic cancer	0.0246	0.036	CbGbCtD
Olanzapine—CYP1A2—Dacarbazine—pancreatic cancer	0.0241	0.0353	CbGbCtD
Olanzapine—ALB—Fluorouracil—pancreatic cancer	0.0236	0.0346	CbGbCtD
Olanzapine—CYP2C19—Tamoxifen—pancreatic cancer	0.0208	0.0304	CbGbCtD
Olanzapine—HRH2—gastric juice—pancreatic cancer	0.0202	0.244	CbGeAlD
Olanzapine—CYP1A2—Tamoxifen—pancreatic cancer	0.0192	0.0281	CbGbCtD
Olanzapine—CYP2C9—Tamoxifen—pancreatic cancer	0.0173	0.0253	CbGbCtD
Olanzapine—HTR3A—enteric nervous system—pancreatic cancer	0.0169	0.204	CbGeAlD
Olanzapine—ABCB1—Tamoxifen—pancreatic cancer	0.0168	0.0246	CbGbCtD
Olanzapine—CYP1A2—Erlotinib—pancreatic cancer	0.0163	0.0239	CbGbCtD
Olanzapine—CYP2D6—Tamoxifen—pancreatic cancer	0.0158	0.0231	CbGbCtD
Olanzapine—ABCB1—Gemcitabine—pancreatic cancer	0.0144	0.0212	CbGbCtD
Olanzapine—ABCB1—Erlotinib—pancreatic cancer	0.0142	0.0209	CbGbCtD
Olanzapine—CYP1A2—Fluorouracil—pancreatic cancer	0.0141	0.0207	CbGbCtD
Olanzapine—CYP2D6—Erlotinib—pancreatic cancer	0.0134	0.0197	CbGbCtD
Olanzapine—ABCB1—Irinotecan—pancreatic cancer	0.0129	0.0189	CbGbCtD
Olanzapine—CYP2C9—Fluorouracil—pancreatic cancer	0.0127	0.0186	CbGbCtD
Olanzapine—HTR7—enteric nervous system—pancreatic cancer	0.0109	0.132	CbGeAlD
Olanzapine—CYP3A4—Tamoxifen—pancreatic cancer	0.01	0.0147	CbGbCtD
Olanzapine—ABCB1—Docetaxel—pancreatic cancer	0.00943	0.0138	CbGbCtD
Olanzapine—ABCB1—Sunitinib—pancreatic cancer	0.00938	0.0138	CbGbCtD
Olanzapine—CYP3A4—Erlotinib—pancreatic cancer	0.00853	0.0125	CbGbCtD
Olanzapine—ORM1—bile—pancreatic cancer	0.00794	0.0959	CbGeAlD
Olanzapine—CYP3A4—Irinotecan—pancreatic cancer	0.00771	0.0113	CbGbCtD
Olanzapine—ABCB1—Doxorubicin—pancreatic cancer	0.00703	0.0103	CbGbCtD
Olanzapine—HTR2A—enteric nervous system—pancreatic cancer	0.00681	0.0823	CbGeAlD
Olanzapine—CYP2D6—Doxorubicin—pancreatic cancer	0.00662	0.0097	CbGbCtD
Olanzapine—CYP3A4—Docetaxel—pancreatic cancer	0.00565	0.00828	CbGbCtD
Olanzapine—CYP3A4—Sunitinib—pancreatic cancer	0.00562	0.00824	CbGbCtD
Olanzapine—CYP3A4—Doxorubicin—pancreatic cancer	0.00421	0.00617	CbGbCtD
Olanzapine—ORM1—gall bladder—pancreatic cancer	0.0022	0.0266	CbGeAlD
Olanzapine—ALB—gall bladder—pancreatic cancer	0.00193	0.0233	CbGeAlD
Olanzapine—H1F0—islet of Langerhans—pancreatic cancer	0.00169	0.0204	CbGeAlD
Olanzapine—HTR3A—islet of Langerhans—pancreatic cancer	0.00161	0.0195	CbGeAlD
Olanzapine—HRH2—digestive system—pancreatic cancer	0.00123	0.0149	CbGeAlD
Olanzapine—H1F0—pancreas—pancreatic cancer	0.00119	0.0144	CbGeAlD
Olanzapine—H1F0—digestive system—pancreatic cancer	0.00102	0.0123	CbGeAlD
Olanzapine—HTR3A—digestive system—pancreatic cancer	0.000969	0.0117	CbGeAlD
Olanzapine—ADRA2A—islet of Langerhans—pancreatic cancer	0.000766	0.00925	CbGeAlD
Olanzapine—HTR2B—digestive system—pancreatic cancer	0.000732	0.00884	CbGeAlD
Olanzapine—ADRA2C—pancreas—pancreatic cancer	0.000675	0.00815	CbGeAlD
Olanzapine—CHRM3—digestive system—pancreatic cancer	0.000659	0.00796	CbGeAlD
Olanzapine—HTR7—digestive system—pancreatic cancer	0.000627	0.00757	CbGeAlD
Olanzapine—CYP2C19—digestive system—pancreatic cancer	0.000612	0.0074	CbGeAlD
Olanzapine—ADRA2A—pancreas—pancreatic cancer	0.000539	0.0065	CbGeAlD
Olanzapine—CYP1A2—digestive system—pancreatic cancer	0.0005	0.00604	CbGeAlD
Olanzapine—CYP2C9—digestive system—pancreatic cancer	0.000475	0.00573	CbGeAlD
Olanzapine—HRH1—digestive system—pancreatic cancer	0.000468	0.00565	CbGeAlD
Olanzapine—ABCB1—islet of Langerhans—pancreatic cancer	0.000427	0.00516	CbGeAlD
Olanzapine—HTR2A—digestive system—pancreatic cancer	0.000391	0.00472	CbGeAlD
Olanzapine—CYP3A4—digestive system—pancreatic cancer	0.000362	0.00437	CbGeAlD
Olanzapine—CYP2D6—digestive system—pancreatic cancer	0.000356	0.0043	CbGeAlD
Olanzapine—ABCB1—pancreas—pancreatic cancer	0.0003	0.00362	CbGeAlD
Olanzapine—ABCB1—digestive system—pancreatic cancer	0.000256	0.0031	CbGeAlD
Olanzapine—CHRM2—Signaling Pathways—CTNNB1—pancreatic cancer	3.37e-06	1.43e-05	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—PIK3CA—pancreatic cancer	3.36e-06	1.43e-05	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—TP53—pancreatic cancer	3.36e-06	1.43e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—MMP9—pancreatic cancer	3.36e-06	1.43e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling by GPCR—HRAS—pancreatic cancer	3.36e-06	1.43e-05	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—APOE—pancreatic cancer	3.36e-06	1.43e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—CTNNB1—pancreatic cancer	3.36e-06	1.43e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—MMP9—pancreatic cancer	3.35e-06	1.43e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—STAT3—pancreatic cancer	3.35e-06	1.42e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—MMP9—pancreatic cancer	3.34e-06	1.42e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—PTEN—pancreatic cancer	3.34e-06	1.42e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—NRAS—pancreatic cancer	3.34e-06	1.42e-05	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—PIK3CD—pancreatic cancer	3.34e-06	1.42e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—PTEN—pancreatic cancer	3.33e-06	1.42e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—MMP9—pancreatic cancer	3.33e-06	1.42e-05	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—PIK3CA—pancreatic cancer	3.33e-06	1.42e-05	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—MYC—pancreatic cancer	3.33e-06	1.42e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—VEGFA—pancreatic cancer	3.33e-06	1.42e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—PTEN—pancreatic cancer	3.32e-06	1.41e-05	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—TGFB1—pancreatic cancer	3.32e-06	1.41e-05	CbGpPWpGaD
Olanzapine—ALB—Metabolism—PIK3CB—pancreatic cancer	3.32e-06	1.41e-05	CbGpPWpGaD
Olanzapine—HTR1B—Signaling Pathways—HRAS—pancreatic cancer	3.31e-06	1.41e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling by GPCR—AKT1—pancreatic cancer	3.31e-06	1.41e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—PTEN—pancreatic cancer	3.31e-06	1.41e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—MMP9—pancreatic cancer	3.3e-06	1.4e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—STAT3—pancreatic cancer	3.29e-06	1.4e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—MMP9—pancreatic cancer	3.29e-06	1.4e-05	CbGpPWpGaD
Olanzapine—ALB—Metabolism—PTGS2—pancreatic cancer	3.29e-06	1.4e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—NRAS—pancreatic cancer	3.29e-06	1.4e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—PTEN—pancreatic cancer	3.28e-06	1.4e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—PTEN—pancreatic cancer	3.27e-06	1.39e-05	CbGpPWpGaD
Olanzapine—ADRA2A—GPCR downstream signaling—AKT1—pancreatic cancer	3.27e-06	1.39e-05	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—HRAS—pancreatic cancer	3.26e-06	1.39e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling by GPCR—AKT1—pancreatic cancer	3.26e-06	1.39e-05	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—EGFR—pancreatic cancer	3.26e-06	1.39e-05	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—TP53—pancreatic cancer	3.26e-06	1.39e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling by GPCR—AKT1—pancreatic cancer	3.25e-06	1.38e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling by GPCR—AKT1—pancreatic cancer	3.24e-06	1.38e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—CASP3—pancreatic cancer	3.24e-06	1.38e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling by GPCR—AKT1—pancreatic cancer	3.23e-06	1.38e-05	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—TP53—pancreatic cancer	3.22e-06	1.37e-05	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—HRAS—pancreatic cancer	3.22e-06	1.37e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—MYC—pancreatic cancer	3.21e-06	1.37e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—TGFB1—pancreatic cancer	3.21e-06	1.36e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling by GPCR—AKT1—pancreatic cancer	3.2e-06	1.36e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—MYC—pancreatic cancer	3.2e-06	1.36e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling by GPCR—AKT1—pancreatic cancer	3.19e-06	1.36e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—TGFB1—pancreatic cancer	3.19e-06	1.36e-05	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—TYMS—pancreatic cancer	3.19e-06	1.36e-05	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	3.18e-06	1.35e-05	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—PIK3CA—pancreatic cancer	3.17e-06	1.35e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Metabolism—PIK3CA—pancreatic cancer	3.16e-06	1.34e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—CCND1—pancreatic cancer	3.15e-06	1.34e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—SRC—pancreatic cancer	3.15e-06	1.34e-05	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—PIK3CD—pancreatic cancer	3.15e-06	1.34e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—EGFR—pancreatic cancer	3.14e-06	1.34e-05	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—PIK3CA—pancreatic cancer	3.13e-06	1.33e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—EGFR—pancreatic cancer	3.13e-06	1.33e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—CTNNB1—pancreatic cancer	3.12e-06	1.33e-05	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—PIK3CD—pancreatic cancer	3.12e-06	1.33e-05	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—HRAS—pancreatic cancer	3.11e-06	1.32e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—MYC—pancreatic cancer	3.11e-06	1.32e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—TGFB1—pancreatic cancer	3.1e-06	1.32e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—SRC—pancreatic cancer	3.1e-06	1.32e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—SRC—pancreatic cancer	3.09e-06	1.32e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—SRC—pancreatic cancer	3.08e-06	1.31e-05	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—HRAS—pancreatic cancer	3.08e-06	1.31e-05	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—KRAS—pancreatic cancer	3.08e-06	1.31e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—SRC—pancreatic cancer	3.07e-06	1.31e-05	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—TP53—pancreatic cancer	3.07e-06	1.31e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—VEGFA—pancreatic cancer	3.07e-06	1.31e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—MYC—pancreatic cancer	3.06e-06	1.3e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—MMP9—pancreatic cancer	3.06e-06	1.3e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—TGFB1—pancreatic cancer	3.05e-06	1.3e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—SRC—pancreatic cancer	3.04e-06	1.29e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—EGFR—pancreatic cancer	3.04e-06	1.29e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—PTEN—pancreatic cancer	3.04e-06	1.29e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—STAT3—pancreatic cancer	3.04e-06	1.29e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—SRC—pancreatic cancer	3.03e-06	1.29e-05	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—PIK3CG—pancreatic cancer	3.03e-06	1.29e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—NRAS—pancreatic cancer	3.03e-06	1.29e-05	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—TP53—pancreatic cancer	3.03e-06	1.29e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—VEGFA—pancreatic cancer	3.02e-06	1.28e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—VEGFA—pancreatic cancer	3.01e-06	1.28e-05	CbGpPWpGaD
Olanzapine—HTR6—Signaling Pathways—AKT1—pancreatic cancer	3.01e-06	1.28e-05	CbGpPWpGaD
Olanzapine—HTR7—Signaling Pathways—AKT1—pancreatic cancer	3.01e-06	1.28e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—VEGFA—pancreatic cancer	3e-06	1.28e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—EGFR—pancreatic cancer	2.99e-06	1.27e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—VEGFA—pancreatic cancer	2.99e-06	1.27e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—STAT3—pancreatic cancer	2.99e-06	1.27e-05	CbGpPWpGaD
Olanzapine—HTR1D—Signaling Pathways—AKT1—pancreatic cancer	2.99e-06	1.27e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—STAT3—pancreatic cancer	2.98e-06	1.27e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—NRAS—pancreatic cancer	2.98e-06	1.27e-05	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—PIK3CB—pancreatic cancer	2.98e-06	1.27e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—NRAS—pancreatic cancer	2.97e-06	1.27e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—STAT3—pancreatic cancer	2.97e-06	1.27e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—KRAS—pancreatic cancer	2.97e-06	1.26e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling by GPCR—AKT1—pancreatic cancer	2.97e-06	1.26e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—NRAS—pancreatic cancer	2.97e-06	1.26e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—VEGFA—pancreatic cancer	2.96e-06	1.26e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—STAT3—pancreatic cancer	2.96e-06	1.26e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—NRAS—pancreatic cancer	2.96e-06	1.26e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—VEGFA—pancreatic cancer	2.96e-06	1.26e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—KRAS—pancreatic cancer	2.95e-06	1.26e-05	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—PTGS2—pancreatic cancer	2.95e-06	1.26e-05	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—HRAS—pancreatic cancer	2.94e-06	1.25e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—STAT3—pancreatic cancer	2.93e-06	1.25e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—NRAS—pancreatic cancer	2.93e-06	1.25e-05	CbGpPWpGaD
Olanzapine—HTR1B—Signaling Pathways—AKT1—pancreatic cancer	2.93e-06	1.25e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—STAT3—pancreatic cancer	2.93e-06	1.25e-05	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—PPARG—pancreatic cancer	2.93e-06	1.25e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—NRAS—pancreatic cancer	2.92e-06	1.24e-05	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—PIK3CB—pancreatic cancer	2.91e-06	1.24e-05	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—HRAS—pancreatic cancer	2.9e-06	1.23e-05	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—PTGS2—pancreatic cancer	2.88e-06	1.23e-05	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—AKT1—pancreatic cancer	2.88e-06	1.23e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—KRAS—pancreatic cancer	2.87e-06	1.22e-05	CbGpPWpGaD
Olanzapine—ALB—Metabolism—PTEN—pancreatic cancer	2.87e-06	1.22e-05	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—AKT1—pancreatic cancer	2.84e-06	1.21e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—KRAS—pancreatic cancer	2.83e-06	1.2e-05	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—PIK3CA—pancreatic cancer	2.83e-06	1.2e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—MYC—pancreatic cancer	2.82e-06	1.2e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—SRC—pancreatic cancer	2.82e-06	1.2e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—TGFB1—pancreatic cancer	2.82e-06	1.2e-05	CbGpPWpGaD
Olanzapine—CHRM3—Metabolism—PIK3CA—pancreatic cancer	2.8e-06	1.19e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—MYC—pancreatic cancer	2.78e-06	1.18e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—MYC—pancreatic cancer	2.77e-06	1.18e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—TGFB1—pancreatic cancer	2.77e-06	1.18e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—TGFB1—pancreatic cancer	2.76e-06	1.18e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—MYC—pancreatic cancer	2.76e-06	1.18e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—EGFR—pancreatic cancer	2.76e-06	1.17e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—TGFB1—pancreatic cancer	2.76e-06	1.17e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—MYC—pancreatic cancer	2.75e-06	1.17e-05	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—AKT1—pancreatic cancer	2.75e-06	1.17e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—TGFB1—pancreatic cancer	2.75e-06	1.17e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—VEGFA—pancreatic cancer	2.75e-06	1.17e-05	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—PIK3CB—pancreatic cancer	2.74e-06	1.17e-05	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—TP53—pancreatic cancer	2.73e-06	1.16e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—PIK3CA—pancreatic cancer	2.73e-06	1.16e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—MYC—pancreatic cancer	2.73e-06	1.16e-05	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—AKT1—pancreatic cancer	2.72e-06	1.16e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—TGFB1—pancreatic cancer	2.72e-06	1.16e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—MYC—pancreatic cancer	2.72e-06	1.16e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—STAT3—pancreatic cancer	2.72e-06	1.16e-05	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—PIK3CB—pancreatic cancer	2.72e-06	1.16e-05	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—PTGS2—pancreatic cancer	2.72e-06	1.16e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—EGFR—pancreatic cancer	2.72e-06	1.16e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—PIK3CA—pancreatic cancer	2.71e-06	1.16e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—TGFB1—pancreatic cancer	2.71e-06	1.15e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—NRAS—pancreatic cancer	2.71e-06	1.15e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—EGFR—pancreatic cancer	2.71e-06	1.15e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—EGFR—pancreatic cancer	2.7e-06	1.15e-05	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—PTGS2—pancreatic cancer	2.69e-06	1.15e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—EGFR—pancreatic cancer	2.69e-06	1.15e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—EGFR—pancreatic cancer	2.67e-06	1.13e-05	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—PIK3CD—pancreatic cancer	2.66e-06	1.13e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—EGFR—pancreatic cancer	2.66e-06	1.13e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—PIK3CA—pancreatic cancer	2.64e-06	1.12e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—TP53—pancreatic cancer	2.64e-06	1.12e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—TP53—pancreatic cancer	2.63e-06	1.12e-05	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—HRAS—pancreatic cancer	2.62e-06	1.11e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—KRAS—pancreatic cancer	2.61e-06	1.11e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—PIK3CA—pancreatic cancer	2.6e-06	1.11e-05	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—AKT1—pancreatic cancer	2.59e-06	1.1e-05	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—APOE—pancreatic cancer	2.59e-06	1.1e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Metabolism—AKT1—pancreatic cancer	2.58e-06	1.1e-05	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—PTEN—pancreatic cancer	2.58e-06	1.1e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—KRAS—pancreatic cancer	2.57e-06	1.09e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Metabolism—PIK3CA—pancreatic cancer	2.56e-06	1.09e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—KRAS—pancreatic cancer	2.56e-06	1.09e-05	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—AKT1—pancreatic cancer	2.56e-06	1.09e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—TP53—pancreatic cancer	2.55e-06	1.09e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—KRAS—pancreatic cancer	2.55e-06	1.09e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—KRAS—pancreatic cancer	2.54e-06	1.08e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—MYC—pancreatic cancer	2.53e-06	1.08e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—HRAS—pancreatic cancer	2.52e-06	1.07e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—TGFB1—pancreatic cancer	2.52e-06	1.07e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—KRAS—pancreatic cancer	2.52e-06	1.07e-05	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—PTEN—pancreatic cancer	2.51e-06	1.07e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—TP53—pancreatic cancer	2.51e-06	1.07e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—KRAS—pancreatic cancer	2.51e-06	1.07e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—HRAS—pancreatic cancer	2.51e-06	1.07e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—EGFR—pancreatic cancer	2.47e-06	1.05e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—HRAS—pancreatic cancer	2.44e-06	1.04e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—HRAS—pancreatic cancer	2.4e-06	1.02e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—PIK3CA—pancreatic cancer	2.4e-06	1.02e-05	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—PTEN—pancreatic cancer	2.37e-06	1.01e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—PIK3CA—pancreatic cancer	2.36e-06	1e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—PIK3CA—pancreatic cancer	2.35e-06	1e-05	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—PTEN—pancreatic cancer	2.35e-06	1e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—PIK3CA—pancreatic cancer	2.34e-06	9.98e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	2.34e-06	9.96e-06	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—PIK3CA—pancreatic cancer	2.34e-06	9.95e-06	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—KRAS—pancreatic cancer	2.33e-06	9.93e-06	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—PIK3CB—pancreatic cancer	2.32e-06	9.88e-06	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—TP53—pancreatic cancer	2.32e-06	9.86e-06	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—PIK3CA—pancreatic cancer	2.31e-06	9.85e-06	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—AKT1—pancreatic cancer	2.31e-06	9.83e-06	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—PIK3CA—pancreatic cancer	2.31e-06	9.82e-06	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—PTGS2—pancreatic cancer	2.3e-06	9.79e-06	CbGpPWpGaD
Olanzapine—CHRM3—Metabolism—AKT1—pancreatic cancer	2.28e-06	9.72e-06	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—TP53—pancreatic cancer	2.28e-06	9.71e-06	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—TP53—pancreatic cancer	2.28e-06	9.68e-06	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—TP53—pancreatic cancer	2.27e-06	9.65e-06	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—TP53—pancreatic cancer	2.26e-06	9.62e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—PPARG—pancreatic cancer	2.26e-06	9.61e-06	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—TP53—pancreatic cancer	2.24e-06	9.53e-06	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—TP53—pancreatic cancer	2.23e-06	9.5e-06	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—AKT1—pancreatic cancer	2.23e-06	9.49e-06	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—AKT1—pancreatic cancer	2.22e-06	9.44e-06	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—HRAS—pancreatic cancer	2.22e-06	9.43e-06	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—HRAS—pancreatic cancer	2.18e-06	9.28e-06	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—HRAS—pancreatic cancer	2.18e-06	9.26e-06	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—HRAS—pancreatic cancer	2.17e-06	9.23e-06	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—HRAS—pancreatic cancer	2.16e-06	9.2e-06	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—AKT1—pancreatic cancer	2.16e-06	9.18e-06	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—PIK3CA—pancreatic cancer	2.14e-06	9.13e-06	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—HRAS—pancreatic cancer	2.14e-06	9.11e-06	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—HRAS—pancreatic cancer	2.14e-06	9.09e-06	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—AKT1—pancreatic cancer	2.12e-06	9.03e-06	CbGpPWpGaD
Olanzapine—ADRA2A—Metabolism—AKT1—pancreatic cancer	2.1e-06	8.92e-06	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—TP53—pancreatic cancer	2.07e-06	8.83e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	2.06e-06	8.75e-06	CbGpPWpGaD
Olanzapine—ALB—Metabolism—PIK3CA—pancreatic cancer	2.02e-06	8.61e-06	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—PTEN—pancreatic cancer	2.01e-06	8.54e-06	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—HRAS—pancreatic cancer	1.98e-06	8.44e-06	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—AKT1—pancreatic cancer	1.96e-06	8.33e-06	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—AKT1—pancreatic cancer	1.93e-06	8.2e-06	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—AKT1—pancreatic cancer	1.92e-06	8.18e-06	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—AKT1—pancreatic cancer	1.92e-06	8.15e-06	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—AKT1—pancreatic cancer	1.91e-06	8.13e-06	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—AKT1—pancreatic cancer	1.89e-06	8.05e-06	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—AKT1—pancreatic cancer	1.89e-06	8.03e-06	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—PIK3CA—pancreatic cancer	1.82e-06	7.73e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	1.79e-06	7.63e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—PTGS2—pancreatic cancer	1.78e-06	7.56e-06	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—PIK3CA—pancreatic cancer	1.77e-06	7.55e-06	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—AKT1—pancreatic cancer	1.75e-06	7.46e-06	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—PIK3CA—pancreatic cancer	1.67e-06	7.11e-06	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—PIK3CA—pancreatic cancer	1.66e-06	7.05e-06	CbGpPWpGaD
Olanzapine—ALB—Metabolism—AKT1—pancreatic cancer	1.65e-06	7.04e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—PTEN—pancreatic cancer	1.55e-06	6.59e-06	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—AKT1—pancreatic cancer	1.48e-06	6.32e-06	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—AKT1—pancreatic cancer	1.45e-06	6.17e-06	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—PIK3CA—pancreatic cancer	1.42e-06	6.03e-06	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—AKT1—pancreatic cancer	1.37e-06	5.81e-06	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—AKT1—pancreatic cancer	1.35e-06	5.76e-06	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—AKT1—pancreatic cancer	1.16e-06	4.92e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	1.09e-06	4.65e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—AKT1—pancreatic cancer	8.93e-07	3.8e-06	CbGpPWpGaD
